These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 8759950)

  • 1. The use of cumulative distributions to determine critical values and levels of confidence for clinical distortion product otoacoustic emission measurements.
    Gorga MP; Stover L; Neely ST; Montoya D
    J Acoust Soc Am; 1996 Aug; 100(2 Pt 1):968-77. PubMed ID: 8759950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From laboratory to clinic: a large scale study of distortion product otoacoustic emissions in ears with normal hearing and ears with hearing loss.
    Gorga MP; Neely ST; Ohlrich B; Hoover B; Redner J; Peters J
    Ear Hear; 1997 Dec; 18(6):440-55. PubMed ID: 9416447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toward optimizing the clinical utility of distortion product otoacoustic emission measurements.
    Stover L; Gorga MP; Neely ST; Montoya D
    J Acoust Soc Am; 1996 Aug; 100(2 Pt 1):956-67. PubMed ID: 8759949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dependence of distortion-product otoacoustic emissions on primary levels in normal and impaired ears. I. Effects of decreasing L2 below L1.
    Whitehead ML; McCoy MJ; Lonsbury-Martin BL; Martin GK
    J Acoust Soc Am; 1995 Apr; 97(4):2346-58. PubMed ID: 7714254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Further efforts to predict pure-tone thresholds from distortion product otoacoustic emission input/output functions.
    Gorga MP; Neely ST; Dorn PA; Hoover BM
    J Acoust Soc Am; 2003 Jun; 113(6):3275-84. PubMed ID: 12822800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting audiometric status from distortion product otoacoustic emissions using multivariate analyses.
    Dorn PA; Piskorski P; Gorga MP; Neely ST; Keefe DH
    Ear Hear; 1999 Apr; 20(2):149-63. PubMed ID: 10229516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Otoacoustic emissions from normal-hearing and hearing-impaired subjects: distortion product responses.
    Gorga MP; Neely ST; Bergman B; Beauchaine KL; Kaminski JR; Peters J; Jesteadt W
    J Acoust Soc Am; 1993 Apr; 93(4 Pt 1):2050-60. PubMed ID: 8473617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of common stimulus parameters on distortion product otoacoustic emission fine structure.
    Johnson TA; Baranowski LG
    Ear Hear; 2012; 33(2):239-49. PubMed ID: 21918451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distortion product otoacoustic emission test performance for a priori criteria and for multifrequency audiometric standards.
    Gorga MP; Neely ST; Dorn PA
    Ear Hear; 1999 Aug; 20(4):345-62. PubMed ID: 10466570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distortion product otoacoustic emission test performance when both 2f1-f2 and 2f2-f1 are used to predict auditory status.
    Gorga MP; Nelson K; Davis T; Dorn PA; Neely ST
    J Acoust Soc Am; 2000 Apr; 107(4):2128-35. PubMed ID: 10790038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distortion product otoacoustic emission suppression tuning curves in normal-hearing and hearing-impaired human ears.
    Gorga MP; Neely ST; Dierking DM; Dorn PA; Hoover BM; Fitzpatrick DF
    J Acoust Soc Am; 2003 Jul; 114(1):263-78. PubMed ID: 12880040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of hearing loss using 2f2-f1 and 2f1-f2 distortion-product otoacoustic emissions.
    Fitzgerald TS; Prieve BA
    J Speech Lang Hear Res; 2005 Oct; 48(5):1165-86. PubMed ID: 16411804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pure-tone threshold estimation from extrapolated distortion product otoacoustic emission I/O-functions in normal and cochlear hearing loss ears.
    Boege P; Janssen T
    J Acoust Soc Am; 2002 Apr; 111(4):1810-8. PubMed ID: 12002865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Relationship between distortion product otoacoustic emissions and pure tone thresholds in normal and hearing-impaired ears].
    Chida E; Satoh N; Kawanami M; Kashiwamura M; Sakamoto T; Fukuda S; Inuyama Y
    Nihon Jibiinkoka Gakkai Kaiho; 1997 Apr; 100(4):436-43. PubMed ID: 9146016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repeatability of distortion product otoacoustic emissions in normally hearing humans.
    Roede J; Harris FP; Probst R; Xu L
    Audiology; 1993; 32(5):273-81. PubMed ID: 8216026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dependence of distortion-product otoacoustic emissions on primary levels in normal and impaired ears. II. Asymmetry in L1,L2 space.
    Whitehead ML; Stagner BB; McCoy MJ; Lonsbury-Martin BL; Martin GK
    J Acoust Soc Am; 1995 Apr; 97(4):2359-77. PubMed ID: 7714255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distortion product otoacoustic emission input/output functions in normal-hearing and hearing-impaired human ears.
    Dorn PA; Konrad-Martin D; Neely ST; Keefe DH; Cyr E; Gorga MP
    J Acoust Soc Am; 2001 Dec; 110(6):3119-31. PubMed ID: 11785813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cochlear generation of intermodulation distortion revealed by DPOAE frequency functions in normal and impaired ears.
    Stover LJ; Neely ST; Gorga MP
    J Acoust Soc Am; 1999 Nov; 106(5):2669-78. PubMed ID: 10573884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Towards understanding the limits of distortion product otoacoustic emission measurements.
    Gorga MP; Neely ST; Bergman BM; Beauchaine KL; Kaminski JR; Liu Z
    J Acoust Soc Am; 1994 Sep; 96(3):1494-500. PubMed ID: 7963014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of systematic primary-tone level variation L2-L1 on the acoustic distortion product emission 2f1-f2 in normal human ears.
    Hauser R; Probst R
    J Acoust Soc Am; 1991 Jan; 89(1):280-6. PubMed ID: 2002169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.